# Clinical Validation of SMD-AFECG for Predicting New-Onset Atrial Fibrillation Within 2 Hours Using Single-Lead ECG Data

> **NCT07722078** · — · NOT_YET_RECRUITING · sponsor: **HUINNO Co., Ltd** · enrollment: 797 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Atrial Fibrillation New Onset

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07722078
- **Lead sponsor:** HUINNO Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 797 (ESTIMATED)
- **Last updated:** 2026-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722078, "Clinical Validation of SMD-AFECG for Predicting New-Onset Atrial Fibrillation Within 2 Hours Using Single-Lead ECG Data". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*